Japan Hernia Repair Devices Market Outlook to 2023
Summary
GlobalData’s new report, "Japan Hernia Repair Devices Market Outlook to 2023", provides key market data on the Japan Hernia Repair Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Synthetic Meshes, Composite Meshes, Biological Meshes and Tack/Staples.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope - Market size and company share data for Hernia Repair Devices market segments - Synthetic Meshes, Composite Meshes, Biological Meshes and Tack/Staples.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the Japan Hernia Repair Devices market.
- Key players covered include Medtronic plc, Ethicon Inc and Others.
Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• Feb 2022
Major players in the fertility services market are Merck KGaA, Care Fertility, INVO Bioscience, Vitrolife, Monash IVF Group, Carolinas Fertility Institute, IntegraMed, Inc., New Hope Fertility Center and Apollo Hospitals Enterprise Ltd. The global fertility services market is expected to grow from $40.73 billion in 2021 to $47.17 billion...
398 pages •
By Global Industry Analysts
• Feb 2022
Abstract: What’s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...
Summary Applied Medical Resources Corporation (Applied Medical), a subsidiary of Applied Medical Corporation is a provider of surgical devices.Its major products include abdominal access systems; laproscopic instrumentation, catheters, stone management products, stealth inserts, endopyelotomy products, occlusion devices,...
The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed...
175 pages •
By The Business Research Company
• May 2021
Major players in the fertility services market are Merck KGaA, Care Fertility, INVO Bioscience, Vitrolife, Monash IVF Group, Carolinas Fertility Institute, IntegraMed, Inc., New Hope Fertility Center, and Apollo Hospitals Enterprise Ltd. The global fertility services market is expected to grow from $16.948 billion in 2020 to $18.475...
295 pages •
By Global Industry Analysts
• Apr 2021
Abstract: - Global Ambulatory Healthcare Services Market to Reach $3.9 Trillion by 2027 - Amid the COVID-19 crisis, the global market for Ambulatory Healthcare Services estimated at US$2.8 Trillion in the year 2020, is projected to reach a revised size of US$3.9 Trillion by 2027, growing at a CAGR of 4.9% over the...
The South & Central America infertility treatment devices and equipment market is expected to reach US$ 108.35 million by 2027 from US$ 62.69 million in 2019. The market is estimated to grow at a CAGR of 7.2% from 2020-2027. The growth of this market can be attributed to key driving factors such as a high rise in the infertility rate and...
Market Introduction Infertility is defined as not being able to get pregnant or conceive.It can be primary infertility (refers to couples who cannot become pregnant after at least 1 year having sex without using birth control methods) and secondary infertility (refers to couples who cannot get pregnant more than once). There are...
The major factors attributing to the growth of the Infertility Treatment Devices market are significant changes in lifestyle which contributed to the rise in infertility and prevalence of conditions such as Polycystic Ovary Syndrome (PCOS). Also, a constant increase in the incidence of infertility in both sexes is projected to drive the market....
Summary BioTelemetry Research (BioTelemetry), formerly Cardiocore, is a subsidiary of BioTelemetry, Inc., healthcare service provider that offers imaging services. The center offers cardiac testing services such as imaging and respiratory testing services. Its services comprise electrocardiography, holter monitoring, ambulatory...
Health Services
Medical Equipment
Japan
APAC
North America
United States
Europe
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.